MedTrace Logo

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

NCT04215510 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 286

Last updated 2021-02-23

No results posted yet for this study

Summary

This study is a multicenter RCT to compare 3-year overall survival(OS) rate, progression free survival(PFS),local progression free survival(LPFS),regional progression free survival(RPFS),distant metastasis free survival(DMFS), and toxicities of endonasal endoscopic surgery versus IMRT.

Conditions

  • Recurrent Nasopharyngeal Carcinoma

Interventions

PROCEDURE

endonasal endoscopic surgery

143 patients will undergo endonasal endoscopic surgery

RADIATION

radiation therapy(IMRT)

143 patients will undergo radiation therapy.

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • Shanghai Municipal Science and Technology Commission

    collaborator OTHER_GOV

  • Eye & ENT Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Hongmeng Yu, MD · Eye&ENT Hospital,Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2027-03-01
Completion
2027-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215510 on ClinicalTrials.gov